The EU AI Act: implications and compliance guidance for healthcare facilities
Frontiers in Digital Health · 10.06.2026 · 8
DOI: 10.3389/fdgth.2026.1808373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Digital Health, online erschienen am 10.06.2026. Verfasst von Fabio Dennstädt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The European Union AI Act [Regulation (EU) 2024/1689] establishes the first comprehensive legal framework for artificial intelligence. While AI offers transformative potential in healthcare, its deployment introduces risks regarding safety, bias, and accountability. There is currently a lack of practical operational frameworks to help healthcare facilities transition from legal theory to clinical compliance.
Methods
We performed a qualitative regulatory analysis of the EU AI Act, specifically focusing on the obligations of “deployers” (Articles 26, 27, and 50) in clinical settings. The Act's requirements were cross-referenced with established clinical governance standards (e.g., MDR 2017/745 and FUTURE-AI guidelines). A 10-step compliance roadmap was synthesized and exemplified through a hypothetical case study of a high-risk multimodal breast cancer AI system.
Results
The analysis identifies healthcare as a primary focus of the Act, with most clinical AI tools classified as “high-risk”. We established a four-phase implementation framework: (1) Foundational Strategy and Governance, (2) System Analysis & Risk Assessment, (3) Operational Integration, and (4) Ongoing Compliance. Key results include the definition of mandatory Fundamental Rights Impact Assessments (FRIA), requirements for site-specific technical validation, and the necessity of establishing trust through structured human oversight mechanisms to mitigate automation bias.
Conclusion
The EU AI Act necessitates a shift from transactional procurement to a lifecycle-spanning compliance partnership between vendors and hospitals. While the administrative burden is substantial, the Act provides the essential framework for the safe scaling of medical AI. Proactive alignment with these standards, particularly regarding AI literacy and human oversight, is a strategic necessity for healthcare facilities to ensure patient safety and regulatory readiness by the August 2026 enforcement deadline.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
- School of Medicine, University of St. Gallen, St. Gallen, Switzerland.
- Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland.
- Swiss Institute of Bioinformatics, Lausanne, Switzerland.
- Department of Radiation Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
- Wemedoo AG, Steinhausen, Switzerland.
Zitieren
APA
Dennstädt, F., Hastings, J., Windisch, P., Jovanovic, A., Marić, T. Ž., Brüningk, S., Aebersold, D. M., Knopf, A., & Cihoric, N. (2026). The EU AI Act: implications and compliance guidance for healthcare facilities. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1808373
Vancouver
Dennstädt F, Hastings J, Windisch P, Jovanovic A, Marić TŽ, Brüningk S, et al. The EU AI Act: implications and compliance guidance for healthcare facilities. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1808373
BibTeX
@article{Dennstdt2026,
author = {Dennstädt, Fabio and Hastings, Janna and Windisch, Paul and Jovanovic, Aleksa and Marić, Tijana Žunić and Brüningk, Sarah and Aebersold, Daniel M and Knopf, Antje and Cihoric, Nikola},
title = {The EU AI Act: implications and compliance guidance for healthcare facilities},
journal = {Frontiers in Digital Health},
year = {2026},
volume = {8},
doi = {10.3389/fdgth.2026.1808373}
}
EUVIMED